Assess Satisfaction of Patients and Physicians With Results of Yaz Plus Treatment for 13 Cycles

A Prospective Multicenter Non-interventional Study on Patients and Physicians Satisfaction of Yaz Plus

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02159261

Enrollment

1500

Registered

2014-06-09

Start date

2014-07-15

Completion date

2016-08-14

Last updated

2017-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Keywords

Personal Satisfaction

Brief summary

Local prospective multicenter non-comparative non-interventional observational study. It's planed to assess satisfaction of patients and physicians with results of Yaz Plus treatment for 13 cycles in real practice.

Detailed description

Non-interventional, Yaz Plus, Contraception, Assess satisfaction, Russian Federation.

Interventions

DRUGBAY98-7071_EE20/DRSP/L-5-MTHF

Patients treated by Physicians under approved local prescriptions

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Female patients ≥ 18 years old * Requiring contraception * Prescribed with Yaz Plus for the first time

Exclusion criteria

* Contraindications for the use of Yaz Plus in accordance with the local product information

Design outcomes

Primary

Measure	Time frame
Satisfaction measured with a Likert response scale (from 1 - poor to 5 - excellent)	Up to 12 months

Secondary

Measure	Time frame
Changes in EVAPIL scale for assessment of tolerability of oral contraceptives.	Baseline to 12 months
Number of participants with adverse events as a measure of safety and tolerability	Up to 12 months

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026